Advertisement

Cytoreduktive Chirurgie oder adjuvante Chirurgie bei metastasierenden Hodentumoren — Vergleich zweier Therapiegruppen

  • R.-H. Ringert
  • H. Behrendt
  • N. Niederle
  • S. Seeber
  • R. Hartung
Conference paper
Part of the Verhandlungsbericht der Deutschen Gesellschaft für Urologie book series (VBDGUROLOGIE, volume 34)

Zusammenfassung

Die multimodale Therapie von Patienten mit ger-minalen Hodentumoren hat in allen großen Behandlungszentren eine erhebliche Besserung der Prognose dieser Erkrankung erbracht. Überlebensraten von 80–90% werden berichtet, betrachtet man Patienten, die den klinischen Stadien I–IIb zugeordnet werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Brenner J, Vugrin D, Whitmore WF (1982) Cyto-reductive Surgery for advanced nonseminomatous germinal tumors of testis. Urology 14:571–574.CrossRefGoogle Scholar
  2. 2.
    Donohue R, Roth J, Zachary J, Rowland R, Einhorn L, Williams S (1982) Cytoreductive surgery for metastatic testis tumors: Tissue analysis of retroperitoneal tumor masses from testis cancer after chemotherapy. 14. International Congress of the International Society of Urology, San Francisco.Google Scholar
  3. 3.
    Javadpour N, Ozols R, Young RC (1982) Prospective randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky disseminated testicular cancer. 77 th Meeting Amer Urolog Assoc, Kansas City.Google Scholar
  4. 4.
    Jones DM, Newlands ES, Begent RHJ, Rustin GJS, Bagshawe KD, Johnson AG, Reynolds KW (1982) The role of abdominal surgery in the treatment of advanced testicular germ cell tumours. Brit J Surg 69:4–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Kloth Ch (1982) Maligne Hodenteratome und die prognostische Wertigkeit der unterschiedlichen Metastasie-rungsmuster. Inaugural-Dissertation, Essen.Google Scholar
  6. 6.
    Richie JP, Garnick MB, Canellos GP (1982) Advances in the treatment of testicular cancer and primary extragonadal germ cell cancer. 14. International Congress of the International Society of Urology, San Francisco.Google Scholar
  7. 7.
    Solé-Baloells F, Garná JR, Algaba F, Villavienci H (1982) Effectiveness and morbidity of secondary retroperitoneal lymph node dissection after chemotherapy in testicular tumors. 14. International Congress of the International Society of Urology, San Francisco.Google Scholar
  8. 8.
    Vugrin D, Whitmore WF, Herr H, Sogani P, Golby R (1982) The response of retroperitoneal lymph node metastases from non-seminomatous germ cell testis cancer to chemotherapy and indications for subsequent surgery. 77 th Meeting Amer Urolog Assoc, Kansas City.Google Scholar
  9. 9.
    Wettlaufer JN, Feiner AS, Robinson WA (1982) Vincristine, cis-platinum and bleomycin with surgery in treatment of metastatic non-seminomatous testicular tumors. 77 th Meeting Amer Urolog Assoc, Kansas CityGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • R.-H. Ringert
    • 1
  • H. Behrendt
  • N. Niederle
  • S. Seeber
  • R. Hartung
  1. 1.Urolog. Univ.-Klinik der GHSEssen 1Deutschland

Personalised recommendations